Rare diseases
Investigational molecules
Locations
1200 G Street Northwest Ste 800, 20005-6705, United States
Tern Therapeutics LLC is focused on the treatment of ocular manifestations associated with Neuronal Ceroid Lipofuscinosis type 2, with attention to the eye-related complications of this rare inherited disorder.
The sponsor’s current clinical research activity is centered on a single ongoing study in this rare pediatric neurodegenerative disease area, reflecting a therapeutic interest in vision-related disease burden.
Tern Therapeutics LLC runs clinical trials in conditions such as Neuronal ceroid lipofuscinosis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
